Miromatrix Medical Inc. Common Stock
MIRO
MIRO was delisted on the 12th of December, 2023.
21 hedge funds and large institutions have $12.6M invested in Miromatrix Medical Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 7 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 3
5% less funds holding
Funds holding: 22 → 21 (-1)
13% less capital invested
Capital invested by funds: $14.5M → $12.6M (-$1.88M)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gagnon Securities
New York
|
+$1.64M |
| 2 |
GA
Gagnon Advisors
New York
|
+$856K |
| 3 |
SIMM
Stillwater Investment Management (Minnesota)
Stillwater,
Minnesota
|
+$336K |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$119K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$99.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$1.18M |
| 2 |
FA
Friess Associates
Greenville,
Delaware
|
-$1.16M |
| 3 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$833K |
| 4 |
GIPM
G2 Investment Partners Management
New York
|
-$342K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$74K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Jane Street
New York
| – | -$57K | -12,212 | Closed |
|
|
SFP
27
Sweet Financial Partners
Fairmont,
Minnesota
| – | -$47K | -10,000 | Closed |
|
MIRO Hedge Fund Activity: Q1 2022 in Review
21 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Miromatrix Medical Inc. Common Stock (MIRO) for Q1 2022, worth a combined $12.6M — down 13% from $14.5M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of MIRO and 6 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 8 added.
The largest buyer was Gagnon Securities, adding an estimated $1.64M. The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $1.18M sold.
- 21 institutional investors held Miromatrix Medical Inc. Common Stock (MIRO) as of Q1 2022, down from 22 in Q4 2021.
- Funds reported $12.6M of Miromatrix Medical Inc. Common Stock stock for Q1 2022, down 13% quarter-over-quarter.
- 6 funds opened new Miromatrix Medical Inc. Common Stock positions in Q1 2022 and 7 closed out, a net change of -1 holder.
- The largest Miromatrix Medical Inc. Common Stock buyer in Q1 2022 was Gagnon Securities, an estimated $1.64M added.
- The largest Miromatrix Medical Inc. Common Stock seller in Q1 2022 was Polar Asset Management Partners, an estimated $1.18M sold.
Based on aggregated 13F filings for Q1 2022.